In a huge breakthrough for complementary medicine, a conventional health journal, The Oncologist, has published a study on how homeopathic medicine has a significant effect on a type of lung cancer.
The study was conducted in 2020 in four outpatient centres across Europe, and evaluated the effects of homeopathic treatment in patients with stage IV advanced non-small cell lung cancer (NSCLC). The patients were randomly assigned to three groups – the control group, the placebo group, and the homeopathy group. 150 patients were involved in the study, and the homeopathy and placebo groups visited the teaching hospital every 9 weeks to have their quality of life assessed. All three groups were observed for survival time after diagnosis.
The results showed that there was a significant improvement in the quality of life of the homeopathy group when compared to the placebo group after 9 and 18 weeks of treatment. In addition, the median survival time was significantly longer in the homeopathy group (435 days) than the placebo group (257 days) and control group (228 days). The homeopathy group also reported that their symptoms were significantly reduced.
The researchers concluded that that homeopathy has a positive effect on quality of life and survival rates in patients with this specific type of cancer, and that further studies with other forms of cancer are warranted.
The full study can be viewed at: https://pubmed.ncbi.nlm.nih.gov/33010094/
This article has been reproduced with the permission of The Complementary Medical Association
References
Frass M, Lechleitner P, Gründling C, Pirker C, Grasmuk-Siegl E, Domayer J, Hochmair M, Gaertner K, Duscheck C, Muchitsch I, Marosi C, Schumacher M, Zöchbauer-Müller S, Manchanda RK, Schrott A, Burghuber O. Homeopathic Treatment as an Add-On Therapy May Improve Quality of Life and Prolong Survival in Patients with Non-Small Cell Lung Cancer: A Prospective, Randomized, Placebo-Controlled, Double-Blind, Three-Arm, Multicenter Study. Oncologist. 2020 Dec;25(12):e1930-e1955. doi: 10.1002/onco.13548. Epub 2020 Nov 7. PMID: 33010094.